Health Care Select Sector SPDR (XLV)

Add to Watchlists Create an Alert
62.85 +0.41  +0.66% NYSE Arca Aug 19, 8:00PM BATS Real time Currency in USD
View Full Chart
XLV Price Chart

XLV Description

Health Care Select Sector SPDR is a long only equity fund managed by SPDR State Street Global Advisors that tracks the S&P Health Care Select Sector TR USD index and has 10.66B USD assets under management. It has an expected distribution yield of 1.59%, a Prospective PE Ratio of 19.95, and a Prospective Price to Book Value of 3.327. The fund has a net expense ratio of 0.16%, turns over its positions 5.43% per year, and is traded on the New York Stock Exchange Arca.

Benchmark Index: S&P Health Care Select Sector TR USD

XLV Key Info

Expense Ratio (1-31-14) 0.16%
Assets Under Management (8-19-14) 10.66B
30-Day Average Volume (8-18-14) 6.760M
Net Asset Value (8-19-14) 62.84
Discount or Premium to NAV (8-19-14) 0.01%
Turnover Ratio (9-30-13) 5.43%

XLV Asset Allocation

Type % Net % Long % Short
Cash 0.19% 0.19% 0.00%
Stock 99.81% 99.81% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Aug. 18, 2014

XLV Region Exposure

Americas 96.61%
North America 96.61%
Latin America 0.00%
Greater Europe 3.39%
United Kingdom 0.00%
Europe Developed 3.39%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Aug. 18, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

XLV Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 99.31%
Industrials 0.00%
Real Estate 0.00%
Technology 0.69%
Utilities 0.00%
As of Aug. 18, 2014

XLV Stock Market Capitalization

Giant 57.37%
Large 37.77%
Medium 4.66%
Small 0.00%
Micro 0.00%
As of Aug. 18, 2014
View More Holdings

XLV Top 10 Holdings

Name % Weight Price Chg %
Johnson & Johnson 12.18% 102.96 +0.25%
Pfizer Inc 7.71% 28.94 +0.35%
Merck & Co Inc 7.16% 58.91 +0.84%
Gilead Sciences Inc 6.48% 101.28 +0.56%
Amgen Inc 4.23% 133.02 -0.15%
AbbVie Inc 3.62% 55.29 +1.80%
Biogen Idec Inc 3.50% 345.84 +0.36%
Bristol-Myers Squibb Company 3.49% 50.30 +0.62%
UnitedHealth Group Inc 3.41% 83.47 +1.37%
Celgene Corp 3.06% 91.36 +0.05%
As of Aug. 18, 2014
Get Quote for
Advertisement

XLV Risk Info

Beta 0.7021
Max Drawdown (12-16-98 to 8-19-14) 40.51%
30 Day Average Volatility 13.09%

XLV Fundamentals

Distribution Yield TTM (8-19-14) 1.59%
Distribution Yield (Prospective) 1.62%
PE Ratio (Prospective) 19.95
PS Ratio (Prospective) 1.749
Price to Book Value (Prospective) 3.327
ROE 20.48%
ROA 8.82%
Number of Holdings 53.00
As of Aug. 18, 2014

XLV Growth Estimates

Forecasted 5 Yr Earnings Growth 9.87%
Forecasted Book Value Growth 9.02%
Forecasted Cash Flow Growth 1.88%
Forecasted Earnings Growth 5.35%
Forecasted Revenue Growth 8.00%
As of Aug. 18, 2014

XLV Performance

  Returns Total Returns
1M 2.33% 2.33%
3M 8.07% 8.47%
6M 6.96% 7.73%
1Y 27.18% 29.16%
3Y 102.0% 113.6%
5Y 126.0% 148.3%
As of Aug. 19, 2014

XLV Flows

1M -665.44M
3M -513.38M
6M -83.71M
YTD 33.47M
1Y 541.89M
3Y 1.738B
5Y 3.095B
As of July 31, 2014
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.